参考文献/References:
[1] Patel NH, Vyas NS, Puri BK, et al. Positron emission tomography in schizophrenia:a new perspective. J Nucl Med, 2010, 51(4):511-520.
[2] Kapur S. Psychosis as a state of aberrant salience:a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry, 2003, 160(1):13-23.
[3] Howes OD, Montgomery A J, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry, 2009, 66(1):13-20.
[4] Elkashef AM, Doudet D, Bryant T, et al. 6-(18) F-DOPA PET study in patients with sehizophrenia. Positron emission tomography. Psychiatry Res 2000, 100(1):1-11.
[5] Takahashi H, Higuehi M, Suhara T. The role of extrastriatal dopamine D2 receptors in schizophrenia. Biol Psychiatry, 2006, 59(10):919-928.
[6] Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature, 1997, 385(6617):634-636.
[7] Yang YK, Yeh TL, Chiu NT, et al. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res, 2004, 131(3):209-216.
[8] Kosaka J, Takahashi H, Ito H, et al. Decreased binding of[11C] NNC112 and[11C] SCH23390 in patients with chronic schizophrenia. Life Sci, 2010, 86(21-22):814-818.
[9] Buchsbaum MS, Christian BT, Lehrer DS, et al. D2/D3 dopamine receptor binding with[F-18] fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res, 2006, 85(1-3):232-244.
[10] Howes OD, Kapur S. The dopamine hypothesis of schizophrenia:version III-the final common pathway. Schizophr Bull, 2009, 35(3):549-562.
[11] Dean B, Crossland N, Boer S, et al. Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia. Schizophr Res, 2008, 104(1-3):185-197.
[12] Alfimova MV, Lezheǐko TV, Golimbet VE, et al. Investigation of association of the brain-derived neurotrophic factor (BDNF) and a serotonin receptor 2A (5-HTR2A) genes with voluntary and involuntary attention in schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova, 2008, 108(4):62-69.
[13] Ngan ET, Yatham LN, Ruth TJ, et al. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia:A PET study using[(18)F] setoperone. Am J Psychiatry, 2000, 157(6):1016-1018.
[14] Gefvert O, Lundberg T, Wieselgren IM, et al. D (2) and 5HT(2A) receptor occupancy of different doses of quetiapinc in schizophrenia:a PET study. Eur Neuropsychopharmacol, 2001, 11(2):105-110.
[15] Mamo D, Kapur S, Shammi CM, et al. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. Am J Psychiatry, 2004, 161(5):818-825.
[16] Fujimoto T, Takeuch K, Matsumoto T, et al. Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Res, 2007, 154(1):49-58.
[17] Kopecek M, Spaniel F, Novák T, et al. 18FDG PET in hallucinating and non-hallucinating patients. Neuro Endocrinol Lett, 2007, 28(1):53-59.
[18] Harrison BJ, Yücel M, Shaw M, et al. Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naïve schizophreniform psychosis. Psychiatry Res, 2006, 148(1):23-31.
[19] Kim JJ, Park HJ, Jung YC, et al. Evaluative processing of ambivalent stimuli in patients with schizophrenia and depression:a[15O] H2O PET study. J Int Neuropsychol Soc, 2009, 15(6):990-1001.
[20] Brewer WJ, Yücel M, Harrison BJ, et al. Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment:longitudinal positron emission tomography study. Aust N Z J Psychiatry, 2007, 41(2):129-135.
[21] Callicott JH, Mattay VS, Bertolino A, et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex, 1999, 9(1):20-26.
[22] Ko JH, Ptito A, Monehi O, et al. Increased dopamine release in the right anterior eingulate cortex during the performance of a sorting task:a[11C] FLB457PET study. Neuroimage, 2009,46(2):516-521.
[23] Arnsten AF. Cateeholamine regulation of the prefrontal cortex. J Psychopharmacol, 1997, 11(2):151-162.
[24] Granon S, Passetti F, Thomas KL, et al. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci, 2000, 20(3):1208-1215.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[3]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[4]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[5]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[6]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[9]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[10]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[11]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[12]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[13]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[14]鲍伟奇,邱春,管一晖.γ-氨基丁酸A型-苯二氮革受体显像剂在神经系统疾病中的应用[J].国际放射医学核医学杂志,2012,36(1):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
BAO Wei-qi,QIU Chun,GUAN Yi-hui.Application of gamma-aminobutyric acid type A-benzodiazepine receptor imaging for study of neuropsychiatric disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(2):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
[15]王相成,王雪梅,何玉林,等.PET-CT表皮生长因子受体显像的研究进展[J].国际放射医学核医学杂志,2010,34(5):266.[doi:10.3760/cma.j.issn.1673-4114.2010.05.003]
WANG Xiang-cheng,WANG Xue-mei,HE Yu-lin,et al.Study progress of PET-CT epidermal growth factor receptor imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):266.[doi:10.3760/cma.j.issn.1673-4114.2010.05.003]
[16]黄顺,韩彦江,郑希,等.靶向表皮生长因子受体小分子类PET显像剂研究进展[J].国际放射医学核医学杂志,2017,41(1):50.[doi:10.3760/cma.j.issn.1673-4114.2017.01.010]
Huang Shun,Han Yanjiang,Zheng Xi,et al.PET imaging agents of small molecules inhibitors targeting EGFR[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(2):50.[doi:10.3760/cma.j.issn.1673-4114.2017.01.010]
[17]刘淼,刘兴党.视网膜神经受体及其分子显像研究进展[J].国际放射医学核医学杂志,2017,41(5):359.[doi:10.3760/cma.j.issn.1673-4114.2017.05.010]
Liu Miao,Liu Xingdang.Review of retinal receptors and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(2):359.[doi:10.3760/cma.j.issn.1673-4114.2017.05.010]